Surgery Partners, Inc. SGRY

14.40 0.20 1.41% as of 25 Sep
Market cap
$1.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
81.58 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.65 0.48 0.27 0.41 0.76 1.74 0.95 1.45 0.86 0.59
P/FCF ratio
8.64 7.07 3.79 10.29 5.39 108.97 26.55 17.21 12.58 8.12
P/Operating CF
22.99 11.86 10.33 29.77 158.99 196.36 335.88 63.47 23.97 19.01
P/B ratio
2.29 0.48 0.43 0.77 1.60 1.96 0.82 1.31 0.84 0.63
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.85 1.98 1.47 1.77 2.13 2.88 1.87 2.39 1.85 1.64
EV/EBITDA
8.79 12.28 16.95 10.06 13.70 15.56 10.07 14.23 11.08 9.22
EV/Operating CF
16.90 22.00 18.07 25.05 16.01 73.68 29.96 22.30 19.23 19.79
EV/FCF
24.58 29.13 21.07 44.14 15.06 180.77 52.22 28.39 27.18 22.42
Quick Ratio
1.55 1.53 1.41 1.05 1.26 1.53 1.50 1.32 1.36 1.37
Current Ratio
1.94 1.86 1.68 1.32 1.44 1.76 1.87 1.71 1.79 1.87
Net Debt/EBITDA
5.70 9.30 13.90 7.71 8.80 6.18 4.95 5.60 5.95 5.88
Debt/Assets
62.57% 47.36% 49.75% 51.42% 52.77% 48.04% 39.24% 40.36% 42.72% 45.60%
Debt/Equity
4.44 1.31 1.60 1.87 2.17 1.49 0.89 0.91 1.05 1.18
Asset Turnover
0.52 0.39 0.38 0.38 0.36 0.39 0.40 0.40 0.42 0.41
Operating CF/Net income
13.25 (1.53) (0.61) (1.17) (1.59) (1.07) (2.91) (24.69) (1.79) (3.52)
Capex/Depreciation
(0.99) (0.57) (0.31) (0.73) 0.16 (0.52) (0.59) (0.53) (0.58) (0.18)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
3.04% (9.52%) (19.55%) (10.61%) (16.68%) (5.69%) (2.22%) (0.40%) (5.40%) (2.46%)
ROA
0.43% (2.28%) (5.12%) (2.28%) (2.98%) (1.41%) (0.85%) (0.18%) (2.28%) (0.97%)
ROIC
7.24% 2.69% 1.35% 3.81% 2.97% 4.18% 4.09% 3.65% 3.46% 3.69%
Return on Tangible Assets
2.49% (12.01%) (35.79%) (16.98%) (19.71%) (7.82%) (4.19%) (0.89%) (10.62%) (4.61%)
Average Days of Receivables
70.29 78.38 63.38 65.15 75.00 70.57 65.59 66.05 67.87 66.43
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
5.26% 5.67% 5.28% 4.84% 2.74% 2.97% 4.02% 4.41% 4.45% 3.57%
Intangible Assets out of Total Assets
0.70 0.74 0.74 0.69 0.65 0.65 0.63 0.64 0.65 0.64
Share Based Compensation of Revenue
0.18% 0.42% 0.52% 0.56% 0.71% 0.78% 0.72% 0.65% 1.07% 0.45%
Graham Net Nets
(2.17) (3.71) (5.59) (4.12) (2.33) (0.83) (1.17) (0.74) (1.34) (1.95)
Graham Number
5.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
1.23% (12.28%) (50.66%) (14.50%) (10.96%) (2.32%) (2.21%) (0.32%) (6.28%) (4.01%)
Free Cash Flow Yield
11.57% 14.15% 26.37% 9.72% 18.55% 0.92% 3.77% 5.81% 7.95% 12.32%
Revenue per Share
23.85 27.76 36.88 37.93 38.14 30.72 27.62 21.84 24.69 26.01
Operating CF per Share
2.61 2.50 3.01 2.68 5.06 1.20 1.73 2.34 2.38 2.16
Capex per Share
(0.81) (0.61) (0.43) (1.16) 0.32 (0.71) (0.74) (0.50) (0.70) (0.25)
Free Cash Flow per Share
1.79 1.89 2.58 1.52 5.38 0.49 0.99 1.84 1.68 1.90
Cash per Share
1.45 3.62 3.84 1.92 6.52 5.38 3.08 1.56 2.14 1.89
Shareholders Equity per Share
6.76 34.51 30.36 28.55 26.99 27.19 31.98 24.16 25.34 24.62
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
6.76 34.51 30.36 28.55 26.99 27.19 31.98 24.16 25.34 24.62
Free Cash Flow
86.13 91.30 124.00 73.50 262.50 35.50 91.10 230.80 212.30 242.10
Working Capital
175.23 260.22 239.00 127.40 244.70 409.30 427.60 372.00 495.00 535.20
Capital Expenditures
(39.11) (29.60) (20.60) (56.00) 15.60 (51.60) (67.70) (63.00) (87.80) (32.20)
Net Current Asset Value
(1,618.33) (2,392.13) (2,629.80) (3,115.00) (3,295.10) (3,201.90) (2,820.20) (2,947.20) (3,574.20) (3,837.70)
EV/EBIT
10.52 16.15 30.13 13.18 20.40 20.47 13.30 19.15 15.67 13.16
Capex to Sales
0.03 0.02 0.01 0.03 (0.01) 0.02 0.03 0.02 0.03 0.01
Net Profit Margin
0.83% (5.90%) (13.44%) (6.03%) (8.37%) (3.65%) (2.15%) (0.43%) (5.40%) (2.35%)
Price to Operating Income
3.79 4.07 6.04 3.21 7.73 12.80 7.01 12.11 7.65 5.05
Other line items
Depreciation/Fixed assets
0.19 0.13 0.16 0.15 0.17 0.16 0.13 0.12 0.14 0.15
Cash ROIC
(4.30%) (6.89%) (7.10%) (9.72%) (6.63%) (10.24%) (12.28%) (11.24%) (11.53%) (12.43%)
Accounts Receivable Turnover
5.74 5.27 5.95 5.77 5.25 5.48 5.73 5.76 5.79 5.60
Accounts Payable Turnover
17.27 15.08 16.21 15.64 15.04 15.40 14.21 12.96 12.45 12.19
Inventory Turnover
30.21 27.50 30.82 31.38 28.83 29.51 29.65 28.59 28.96 27.50
Average Days of Payables
22.12 30.50 22.33 25.08 24.71 26.30 28.17 29.92 32.16 29.95
Days of Inventory on Hand
12.79 16.18 11.64 12.01 13.91 12.86 13.27 13.10 13.62 13.86
Average Receivables
199.71 254.31 297.81 317.25 354.55 406.20 443.25 476.35 537.75 590.65
Average Payables
47.55 67.24 84.01 90.00 98.45 112.55 138.25 161.70 190.25 208.70
Average Inventory
27.18 36.86 44.18 44.85 51.35 58.75 66.25 73.30 81.80 92.50
Average Assets
2,204.70 3,463.87 4,649.54 4,847.60 5,216.05 5,765.40 6,399.85 6,779.40 7,383.35 8,004.85
Average Common Equity
311.30 830.64 1,217.76 1,041.15 932.75 1,425.85 2,455.25 2,987.70 3,115.45 3,163.85

Fold the line items

Columns are period end dates